Susan ALTSCHULLER

CIK 1817988 · Chief Financial Officer · last filed 2026-01-08

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

4

Total Filings

14

Lifetime Open-Market Net

-$539.9K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Climb Bio, Inc. (ELYM) Delisted Chief Financial Officer $5.11 $0 2 2026-01-08
Mural Oncology plc (MURAV) Delisted Director 10,000 $32.1K 4 2024-08-15
Cerevel Therapeutics Holdings, Inc. (CERE) Delisted Chief Financial Officer 30,721 $44.96 $1.38M -$572.0K 3 2024-01-23
ImmunoGen, Inc. (IMGN) Delisted SVP AND CFO $31.23 $0 4 2022-12-27

Recent Filings · Page 2 of 2

14 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2022-12-27 ImmunoGen, Inc. (IMGN) Delisted Grant (A) $0 EDGAR
2022-02-08 ImmunoGen, Inc. (IMGN) Delisted Grant (A) $0 EDGAR
2021-02-09 ImmunoGen, Inc. (IMGN) Delisted Grant (A) $0 EDGAR
2020-07-22 ImmunoGen, Inc. (IMGN) Delisted Grant (A) $0 EDGAR
Showing 1114 of 14
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.